Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$31.82

0.16 (0.51%)

07:35
12/14/16
12/14
07:35
12/14/16
07:35

Jefferies cuts Sarepta target on slower than expected launch

Jefferies analyst Gena Wang cut her price target for Sarepta Therapeutics to $32 from $46 after her due diligence revealed stronger payer pushback and a slower launch for Exondys 51, the company's' recently approved treatment of Duchenne muscular dystrophy. After speaking with four private payers, three Medicaid experts and "several" Duchenne muscular dystrophy experts with "first-hand experience" of Exondys 51, Wang believes the majority of patients being under Medicaid as well as restrictive payer policies could further slow the launch of Exondys 51 in the near term. Based on available data, three of five national and eight of 15 regional managed care organizations have denied or restricted coverage for Exondys 51, the analyst tells investors in a research note. Wang keeps a Hold rating on Sarepta shares.

SRPT Sarepta
$31.82

0.16 (0.51%)

11/11/16
LEER
11/11/16
NO CHANGE
Target $55
LEER
Market Perform
Sarepta Exondys 51 launch expectations seem too high for 2017, says Leerink
Leerink analyst Joseph Schwartz believes Sarepta Exondys 51 launch expectations may be too high for 2017. While nothing that a true Duchenne muscular dystrophy prevalence remains unknown, the analyst says that a "start form" number of about 200 patients would need to be provided in early January in order for investors to be confident in 2017 consensus sales estimates of $215M. Additionally, Schwartz points out that based on the price of Exondys 51 per vial, it currently appears that management has underestimated the true price of the drug which they will realize.
11/29/16
BARD
11/29/16
NO CHANGE
Target $102
BARD
Outperform
Baird sees strong launch for Sarepta after surveying neurologists
After his firm surveyed 30 neurologists treating at least ten Duchenne muscular dystrophy patients and at least five suspected/confirmed patients amenable to exon-51 skipping, Baird analyst Brian Skorney believes Sarepta Therapeutics' Exondys 51 is positioned for a strong launch. In a research note earlier today, Skorney said that most of the 30 doctors surveyed seem convinced of the drug's efficacy, and plan to start prescribing the drug in the next year. The drug's consensus sales estimate for its first quarter on the market of $7.1M may be understating sales, Skorney wrote. The analyst continues to expect $11M of Exondys 51 sales in Q4. He has an Outperform rating on shares of Sarepta with a $102 price target. The stock is up 34c, or 1%, to $36.62 in morning trading.
12/01/16
RBCM
12/01/16
NO CHANGE
RBCM
Outperform
Sarepta DMD drug still likely to be covered by UnitedHealth, says RBC Capital
RBC Capital analyst Simos Simeonidis said some language in UnitedHealthcare's (UNH) Commercial Drug Policy for Sarepta's (SRPT) Exondys 51 may have "spooked" investors, but he continues to believe that the DMD drug will end up being covered by the insurer. The analyst, who would be a buyer of Sarepta amid this weakness, keeps an Outperform rating on the stock.
12/01/16
FBCO
12/01/16
NO CHANGE
FBCO
Outperform
UnitedHealth policy for Exondys 51 a positive for Sarepta, says Credit Suisse
Credit Suisse analyst Alethia Young noted that Sarepta (SRPT) shares have been weak since UnitedHealth (UNH) posted its medical benefit policy for the company's DMD drug Exondys 51, but she doesn't see a reason for the weakness. She doesn't think encouraging home infusions limits access and believes the requirement for an every 6 month reauthorization is neither "prohibitive nor concerning" as it is standard with expensive rare disease treatments. She sees the policy as a positive for Sarepta, as having more payers supporting Exondys reimbursement makes it hard for other payers not to do so, and keeps an Outperform rating on Sarepta shares.

TODAY'S FREE FLY STORIES

04:55
01/21/17
01/21
04:55
01/21/17
04:55
Conference/Events
Peters & Co. hold a conference »

Limited Energy Conference…

ETFC

E-Trade

$36.39

0.15 (0.41%)

04:55
01/21/17
01/21
04:55
01/21/17
04:55
Conference/Events
E*Trade to hold education day »

E*Trade's Education…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

AMGN

Amgen

$154.67

0.87 (0.57%)

, BAYRY

Bayer

$109.31

0.98 (0.90%)

04:55
01/21/17
01/21
04:55
01/21/17
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2017 Gastrointestinal…

AMGN

Amgen

$154.67

0.87 (0.57%)

BAYRY

Bayer

$109.31

0.98 (0.90%)

BMY

Bristol-Myers

$49.23

-6.26 (-11.28%)

CCXI

ChemoCentryx

$7.56

-0.32 (-4.06%)

CELG

Celgene

$112.66

-0.96 (-0.84%)

DNA

Bought by RHHBY

EXEL

Exelixis

$17.92

0.02 (0.11%)

HALO

Halozyme

$11.50

0.42 (3.79%)

LXRX

Lexicon

$13.84

-0.19 (-1.35%)

MACK

Merrimack

$3.00

-0.05 (-1.64%)

MRK

Merck

$62.53

2.2 (3.65%)

NVS

Novartis

$70.65

0.22 (0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 26

    Jan

  • 26

    Jan

  • 01

    Feb

  • 02

    Feb

  • 12

    Feb

  • 16

    Feb

  • 21

    Feb

  • 23

    Feb

  • 24

    Feb

  • 28

    Feb

  • 02

    Mar

  • 08

    Mar

  • 15

    Mar

  • 10

    May

  • 27

    May

  • 19

    Jul

KATE

Kate Spade

$17.76

-0.07 (-0.39%)

, COH

Coach

$35.31

0.21 (0.60%)

18:54
01/20/17
01/20
18:54
01/20/17
18:54
Periodicals
Kate Spade draws interest from Coach, Michael Kors, Bloomberg reports »

Kate Spade (KATE) is…

KATE

Kate Spade

$17.76

-0.07 (-0.39%)

COH

Coach

$35.31

0.21 (0.60%)

KORS

Michael Kors

$42.46

0.43 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

CTIC

CTI BioPharma

$4.97

-0.1 (-1.97%)

18:14
01/20/17
01/20
18:14
01/20/17
18:14
Hot Stocks
CTI BioPharma regains compliance with Nasdaq Listing Rule »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$40.46

0.06 (0.15%)

18:06
01/20/17
01/20
18:06
01/20/17
18:06
Hot Stocks
Abbott sponsored study shows SCS therapy can reduce, stabilize opioid use »

New research has found…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 21

    Feb

WMT

Wal-Mart

$67.18

-0.44 (-0.65%)

18:02
01/20/17
01/20
18:02
01/20/17
18:02
Periodicals
Wal-Mart begins corporate job cuts at headquarters, WSJ reports »

Wal-Mart has started on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COH

Coach

$35.31

0.21 (0.60%)

, KORS

Michael Kors

$42.46

0.43 (1.02%)

17:46
01/20/17
01/20
17:46
01/20/17
17:46
Periodicals
Breaking Periodicals news story on Coach, Michael Kors, Kate Spade »

Coach, Michael Kors to…

COH

Coach

$35.31

0.21 (0.60%)

KORS

Michael Kors

$42.46

0.43 (1.02%)

KATE

Kate Spade

$17.76

-0.07 (-0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

BELFB

Bel Fuse

$31.80

0.2 (0.63%)

17:33
01/20/17
01/20
17:33
01/20/17
17:33
Hot Stocks
Gabelli reports 23.15% stake in Bel Fuse »

GAMCO, pursuant to Rule…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMD

ResMed

$63.65

0.75 (1.19%)

17:32
01/20/17
01/20
17:32
01/20/17
17:32
Hot Stocks
ResMed, BMC, 3B Medical settle global litigation »

ResMed, BMC, and 3B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOG

Northern Oil and Gas

$3.50

0.05 (1.45%)

17:27
01/20/17
01/20
17:27
01/20/17
17:27
Hot Stocks
Breaking Hot Stocks news story on Northern Oil and Gas »

Elliott Associates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTE

Baytex Energy

$4.06

0.01 (0.25%)

17:12
01/20/17
01/20
17:12
01/20/17
17:12
Hot Stocks
Baytex Energy closes Peace River acquisition »

Baytex Energy closed its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FGEN

FibroGen

$25.60

1 (4.07%)

17:09
01/20/17
01/20
17:09
01/20/17
17:09
Hot Stocks
FibroGen 'encouraged' by updated pamrevlumab clinical data »

FibroGen announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IIPR

Innovative Industrial Properties

$18.86

-0.199 (-1.04%)

17:03
01/20/17
01/20
17:03
01/20/17
17:03
Hot Stocks
Breaking Hot Stocks news story on Innovative Industrial Properties »

Alan D. Gold raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SITE

SiteOne Landscape

$37.26

0.41 (1.11%)

17:03
01/20/17
01/20
17:03
01/20/17
17:03
Hot Stocks
SiteOne Landscape acquires Aspen Valley Landscape Supply »

SiteOne Landscape…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITCB

Itau Corpbanca

$12.55

-0.08 (-0.63%)

17:01
01/20/17
01/20
17:01
01/20/17
17:01
Hot Stocks
Itau Corpbanca files Material Event Notice »

Itau Corpbanca announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$232.20

0.79 (0.34%)

16:50
01/20/17
01/20
16:50
01/20/17
16:50
Hot Stocks
Goldman Sachs chief accounting officer Smith to become global head of compliance »

Goldman Sachs said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DTEA

DAVIDsTEA

$6.65

0.1 (1.53%)

16:47
01/20/17
01/20
16:47
01/20/17
16:47
Hot Stocks
DAVIDsTEA announces two leadership departures »

DAVIDsTEA's Chief HR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Wal-Mart

$67.18

-0.44 (-0.65%)

, BAYRY

Bayer

$109.31

0.98 (0.90%)

16:47
01/20/17
01/20
16:47
01/20/17
16:47
General news
On The Fly: Stocks end week mixed as Trump takes office »

Stocks ended the week…

WMT

Wal-Mart

$67.18

-0.44 (-0.65%)

BAYRY

Bayer

$109.31

0.98 (0.90%)

GM

General Motors

$37.01

-0.29 (-0.78%)

NFLX

Netflix

$138.60

0.19 (0.14%)

XOM

Exxon Mobil

$85.89

1.16 (1.37%)

JCP

J.C. Penney

$6.85

0.16 (2.39%)

NKE

Nike

$53.20

0.27 (0.51%)

CSX

CSX

$44.33

-1.18 (-2.59%)

CP

Canadian Pacific

$150.99

0.68 (0.45%)

FWP

Forward Pharma

$30.76

2.01 (6.99%)

CWEI

Clayton Williams

$146.85

-1.18 (-0.80%)

NBL

Noble Energy

$40.21

-0.06 (-0.15%)

RAI

Reynolds American

$58.71

0.13 (0.22%)

BTI

British American Tobacco

$117.30

0.54 (0.46%)

LLY

Eli Lilly

$76.81

-0.03 (-0.04%)

CLCD

CoLucid Pharmaceuticals

$46.25

-0.05 (-0.11%)

WBA

Walgreens Boots Alliance

$81.72

-1.77 (-2.12%)

RAD

Rite Aid

$7.46

-1.14 (-13.26%)

TGT

Target

$64.10

-1.29 (-1.97%)

GIMO

Gigamon

$34.20

1.35 (4.11%)

PSO

Pearson

FAST

Fastenal

$51.24

0.69 (1.37%)

CHKP

Check Point

$97.79

1.45 (1.51%)

PG

Procter & Gamble

$87.45

2.75 (3.25%)

IBM

IBM

$170.55

3.74 (2.24%)

SWKS

Skyworks

$88.67

10.21 (13.01%)

MS

Morgan Stanley

$42.59

0.14 (0.33%)

PRGS

Progress Software

$28.18

0.16 (0.57%)

CMA

Comerica

$66.96

0.65 (0.98%)

UNH

UnitedHealth

$158.66

-0.04 (-0.03%)

GS

Goldman Sachs

$232.20

0.79 (0.34%)

C

Citi

$56.11

-0.55 (-0.97%)

RCII

Rent-A-Center

$8.40

0.09 (1.08%)

GE

General Electric

$30.53

-0.68 (-2.18%)

AXP

American Express

$76.20

-0.49 (-0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jan

  • 20

    Jan

  • 24

    Jan

  • 26

    Jan

  • 26

    Jan

  • 31

    Jan

  • 02

    Feb

  • 07

    Feb

  • 13

    Feb

  • 14

    Feb

  • 14

    Feb

  • 16

    Feb

  • 20

    Feb

  • 21

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 19

    Apr

TSO

Tesoro

$80.48

-0.08 (-0.10%)

16:42
01/20/17
01/20
16:42
01/20/17
16:42
Hot Stocks
Breaking Hot Stocks news story on Tesoro »

Point72 Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$42.59

0.14 (0.33%)

, OIBR

Oi S.A.

16:40
01/20/17
01/20
16:40
01/20/17
16:40
Hot Stocks
Breaking Hot Stocks news story on Morgan Stanley, Oi S.A.  »

Morgan Stanley reports 5%…

MS

Morgan Stanley

$42.59

0.14 (0.33%)

OIBR

Oi S.A.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UMH

UMH Properties

16:36
01/20/17
01/20
16:36
01/20/17
16:36
Hot Stocks
UMH Properties closes acquisition of two Ohio communities for about $9.6M »

UMH Properties announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIOP

Bioptix

$3.43

0.01 (0.29%)

16:36
01/20/17
01/20
16:36
01/20/17
16:36
Hot Stocks
Bioptix announces workforce reductions »

Bioptix adopted a plan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVX

Chevron

$115.60

0.02 (0.02%)

16:35
01/20/17
01/20
16:35
01/20/17
16:35
Hot Stocks
Court rejects attempt to enforce Ecuadorian judgment against Chevron unit »

A Canadian court has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

  • 23

    Mar

MIME

Mimecast

$21.42

-0.95 (-4.25%)

16:34
01/20/17
01/20
16:34
01/20/17
16:34
Syndicate
Breaking Syndicate news story on Mimecast »

Mimecast files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Feb

  • 13

    Feb

  • 27

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.